Geno4ME will be returning the results of two panels, the Inherited Disease panel and the Pharmacogenomics panel.
- The Inherited Disease panel reports genes with high penetrance (high probability that disease will appear when a disease-related genotype is present), such as Lynch syndrome, hereditary breast and ovarian cancer syndrome, and familial hypercholesterolemia. Each of these hereditary disorders has well-established, effective, guideline-based interventions that are known to substantially prevent or mitigate disease risk.
- The Pharmacogenomics panel reports clinically actionable drug/gene pairs for a handful of commonly prescribed medications, including citalopram, omeprazole, and clopidogrel. The reported drug/gene pairs were selected because they have both published pharmacogenomic-based drug dosing guidelines and FDA drug labels containing pharmacogenomic information.
For the complete list of the Geno4ME Inherited Disease and Pharmacogenomics panels, CLICK HERE.
For more detailed information about the reported genes and their related conditions, or pharmacogenomics, and to access Just in Time (JIT) documents to help you guide your patient’s care, CLICK HERE.
